Product Description:
Glyxambi contains two active substances called empagliflozin and linagliptin. Each belongs to a group of medicines called "oral antidiabetics."
These are oral medications used to treat type 2 diabetes.
Glyxambi is added to metformin or sulfonylurea (SU) to treat type 2 diabetes in adults aged 18 years and older whose diabetes cannot be controlled when treated with metformin or sulfonylurea plus empagliflozin, or when treated with metformin or sulfonylurea plus linagliptin.
Glyxambi can also be used as a substitute for taking both empagliflozin and linagliptin as separate tablets.
To avoid overdose, do not continue taking empagliflozin and linagliptin tablets separately if you are taking this medication.
It is important to continue following the nutrition and exercise plan recommended by your doctor, pharmacist, or nurse.
Usage Instructions:
Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are unsure.
Dosage:
The usual starting dose is one film-coated tablet of Glyxambi 10 mg / 5 mg (10 mg empagliflozin and 5 mg linagliptin) once daily.
Your doctor will decide if you need to increase your dose to one film-coated tablet of Glyxambi 25 mg / 5 mg (25 mg empagliflozin and 5 mg linagliptin) once daily.
If you are already taking 25 mg empagliflozin and 5 mg linagliptin as separate tablets and switch to Glyxambi, you can start directly with Glyxambi 25 mg / 5 mg.
Ingredients:
The active substances are empagliflozin and linagliptin. Each film-coated tablet contains 25 mg empagliflozin and 5 mg linagliptin.
Product Details:
Brand: Glyxambi
